US Patent Issued to BEIJING WISDOMAB BIOTECHNOLOGY, GENRIX (SHANGHAI) BIOPHARMACEUTICAL, CHONGQING GENRIX BIOPHARMACEUTICAL on June 9 for "Antibody for tetanus toxin and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,777, issued on June 9, was assigned to BEIJING WISDOMAB BIOTECHNOLOGY Co. LTD (Daxing District, China), GENRIX (SHANGHAI) BIOPHARMACEUTICAL Co. LTD. (Pudong District, China) and CHONGQING GENRIX BIOPHARMACEUTICAL Co. LTD. (Chongqing, China).

"Antibody for tetanus toxin and use thereof" was invented by Zhigang Liu (Beijing), Xiaowei Zhou (Beijing), Yulan Liu (Beijing), Xiaobo Hao (Beijing) and Junjie Hu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a bispecific antibody and a monoclonal antibody for a tetanus toxin, and uses of the antibodies. The bispecific antibody contains a first antigen-binding fragment and a second antigen...